Anephrogenic phenotype induced by SALL1 gene knockout in pigs.
Allografts
/ supply & distribution
Animals
Animals, Genetically Modified
CRISPR-Cas Systems
/ genetics
Feasibility Studies
Female
Fetal Development
/ genetics
Gene Editing
/ methods
Gene Expression Regulation, Developmental
Gene Knockout Techniques
Humans
Kidney Transplantation
Male
Mutation
Nephrons
/ growth & development
Pluripotent Stem Cells
/ physiology
Regeneration
/ physiology
Sus scrofa
Tissue Engineering
/ methods
Transcription Activator-Like Effector Nucleases
/ genetics
Transcription Factors
/ genetics
Zygote
/ growth & development
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
29 05 2019
29 05 2019
Historique:
received:
11
12
2018
accepted:
13
05
2019
entrez:
31
5
2019
pubmed:
31
5
2019
medline:
21
10
2020
Statut:
epublish
Résumé
To combat organ shortage in transplantation medicine, a novel strategy has been proposed to generate human organs from exogenous pluripotent stem cells utilizing the developmental mechanisms of pig embryos/foetuses. Genetically modified pigs missing specific organs are key elements in this strategy. In this study, we demonstrate the feasibility of using a genome-editing approach to generate anephrogenic foetuses in a genetically engineered pig model. SALL1 knockout (KO) was successfully induced by injecting genome-editing molecules into the cytoplasm of pig zygotes, which generated the anephrogenic phenotype. Extinguished SALL1 expression and marked dysgenesis of nephron structures were observed in the rudimentary kidney tissue of SALL1-KO foetuses. Biallelic KO mutations of the target gene induced nephrogenic defects; however, biallelic mutations involving small in-frame deletions did not induce the anephrogenic phenotype. Through production of F1 progeny from mutant founder pigs, we identified mutations that could reliably induce the anephrogenic phenotype and hence established a line of fertile SALL1-mutant pigs. Our study lays important technical groundwork for the realization of human kidney regeneration through the use of an empty developmental niche in pig foetuses.
Identifiants
pubmed: 31142767
doi: 10.1038/s41598-019-44387-w
pii: 10.1038/s41598-019-44387-w
pmc: PMC6541644
doi:
Substances chimiques
Transcription Factors
0
Transcription Activator-Like Effector Nucleases
EC 3.1.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
8016Références
Development. 1996 Mar;122(3):983-95
pubmed: 8631275
Nature. 2013 Jul 25;499(7459):481-4
pubmed: 23823721
J Am Soc Nephrol. 2016 Jun;27(6):1778-91
pubmed: 26586691
Nucleic Acids Res. 2014 Apr;42(6):e42
pubmed: 24381193
Nat Rev Genet. 2007 Oct;8(10):791-802
pubmed: 17878895
Cell Res. 2013 May;23(5):720-3
pubmed: 23545779
Am J Pathol. 2012 Jun;180(6):2417-26
pubmed: 22507837
J Reprod Dev. 2012;58(5):599-608
pubmed: 22785381
Cell. 2014 Feb 13;156(4):836-43
pubmed: 24486104
Nat Commun. 2013;4:1367
pubmed: 23340407
J Mol Cell Cardiol. 2016 Mar;92:158-62
pubmed: 26876450
Mech Dev. 1996 Jan;54(1):95-105
pubmed: 8808409
Exp Anim. 2014;63(1):79-84
pubmed: 24521866
Nat Biotechnol. 2013 Jan;31(1):23-4
pubmed: 23302927
Oncotarget. 2017 Dec 14;8(70):115480-115489
pubmed: 29383175
Hum Mol Genet. 2015 Jul 1;24(13):3764-74
pubmed: 25859012
Cell. 1993 Aug 27;74(4):679-91
pubmed: 8395349
Development. 2001 Aug;128(16):3105-15
pubmed: 11688560
Development. 1997 Oct;124(20):4077-87
pubmed: 9374404
Proc Natl Acad Sci U S A. 2012 Oct 23;109(43):17382-7
pubmed: 23027955
Science. 2009 Jul 24;325(5939):433
pubmed: 19628861
Sci Rep. 2013 Nov 29;3:3379
pubmed: 24287550
Cell. 2010 Sep 3;142(5):787-99
pubmed: 20813264
Development. 2006 Aug;133(15):3005-13
pubmed: 16790473
J Pediatr. 2013 Mar;162(3):612-7
pubmed: 23069192
Cell. 2013 May 9;153(4):910-8
pubmed: 23643243
Reprod Domest Anim. 2016 Oct;51 Suppl 2:18-24
pubmed: 27762052
Genome Res. 2014 Jun;24(6):1012-9
pubmed: 24696461
Dev Biol. 2015 Oct 15;406(2):222-34
pubmed: 26321050
Proc Natl Acad Sci U S A. 2013 Oct 8;110(41):16526-31
pubmed: 24014591
Development. 2015 Sep 1;142(17):3009-20
pubmed: 26253404
Nat Biotechnol. 2011 Aug 05;29(8):695-6
pubmed: 21822240
Dev Biol. 2019 Jan 15;445(2):156-162
pubmed: 30359560
Proc Natl Acad Sci U S A. 2013 Mar 19;110(12):4557-62
pubmed: 23431169
Genome Res. 2014 Jan;24(1):125-31
pubmed: 24253447
Development. 2001 Dec;128(23):4747-56
pubmed: 11731455
Sci Rep. 2017 Sep 5;7(1):10487
pubmed: 28874671
Methods Mol Biol. 2016;1338:61-70
pubmed: 26443214
Development. 2001 Apr;128(7):1045-57
pubmed: 11245570
Cell Stem Cell. 2014 Oct 2;15(4):406-409
pubmed: 25280216
Hum Mol Genet. 2003 Sep 1;12(17):2221-7
pubmed: 12915476
PLoS One. 2013 Apr 23;8(4):e61900
pubmed: 23626746
Nature. 1995 Jul 6;376(6535):62-6
pubmed: 7596435
Cell. 2017 Jan 26;168(3):473-486.e15
pubmed: 28129541
Nucleic Acids Res. 2013 Jun;41(11):e120
pubmed: 23630316
Sci Rep. 2017 Feb 03;7:42081
pubmed: 28155910
Dev Biol. 2016 Oct 1;418(1):1-9
pubmed: 27474397
Dev Biol. 2014 Sep 1;393(1):3-9
pubmed: 24984260
Nat Immunol. 2016 Dec;17(12):1397-1406
pubmed: 27776109
Nucleic Acids Res. 2013 Nov;41(20):e187
pubmed: 23997119
Mol Cell Biol. 2014 May;34(9):1649-58
pubmed: 24567370
Transgenic Res. 2016 Aug;25(4):533-44
pubmed: 26931321
Front Immunol. 2013 Jul 12;4:187
pubmed: 23874334
J Reprod Dev. 2008 Jun;54(3):208-13
pubmed: 18408352
Nat Biotechnol. 2013 Aug;31(8):681-3
pubmed: 23929336
Theriogenology. 2016 Jul 1;86(1):422-6
pubmed: 27156683
Nat Genet. 1998 Jan;18(1):81-3
pubmed: 9425907